Vadadustat is an orally administered small molecule that inhibits hypoxia-inducible factor prolyl-hydroxylase (HIF-PH), thereby mimicking hypoxic conditions to stimulate erythropoiesis. It is used as an active pharmaceutical ingredient in the management of anemia associated with chronic kidney disease in adults on maintenance dialysis.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1000025-07-9
Cis-Etoposide
Active pharmaceutical ingredient
SULOPENEM ETZADROXIL
prodrug antibacterial active pharmaceutical ingredient
Tegobuvir
non-structural protein 5B polymerase inhibitor
Tivantinib
c-Met inhibitor
3-PHENYLPYRIDINE
n.a
2-(Pyridin-3-yl)benzoic acid
research compound
2-(Pyridin-3-yl)-5-(trifluoromethyl)benzenamine
n.a
B-(4-(3-Pyridinyl)phenyl)boronic acid
Research chemical for organic synthesis
2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
JGRXMPYUTJLTKT-UHFFFAOYSA-N
C1=CC(=CC(=C1)Cl)C2=CC(=C(N=C2)C(=O)NCC(=O)O)O